| scholarly article | Q13442814 |
| P2093 | author name string | Joseph M Backer | |
| Marina V Backer | |||
| Francis G Blankenberg | |||
| Zoya Levashova | |||
| Kevin Claffey | |||
| Brian T Jehning | |||
| Vimalkumar Patel | |||
| P2860 | cites work | Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors | Q24678647 |
| Nontransgenic models of breast cancer | Q24800700 | ||
| The biology of VEGF and its receptors | Q27860704 | ||
| Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 | ||
| Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. | Q31043193 | ||
| Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies | Q31059628 | ||
| Promises and pitfalls of anti-angiogenic therapy in clinical trials | Q35076995 | ||
| Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis | Q35692056 | ||
| The anti-angiogenic basis of metronomic chemotherapy | Q35788112 | ||
| Imaging angiogenesis: applications and potential for drug development | Q36027611 | ||
| Lessons from phase III clinical trials on anti-VEGF therapy for cancer | Q36366446 | ||
| Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag. | Q40255479 | ||
| In vivo tumor angiogenesis imaging with site-specific labeled (99m)Tc-HYNIC-VEGF. | Q40280042 | ||
| Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature | Q40388042 | ||
| Functionally active VEGF fusion proteins | Q40778735 | ||
| Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects | Q41941549 | ||
| Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes | Q43992762 | ||
| Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia | Q48600277 | ||
| Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy | Q57168246 | ||
| Characterization of123I-vascular endothelial growth factor-binding sites expressed on human tumour cells: Possible implication for tumour scintigraphy | Q57168258 | ||
| Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models | Q73365474 | ||
| Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue | Q73562679 | ||
| Targeting endothelial cells overexpressing VEGFR-2: selective toxicity of Shiga-like toxin-VEGF fusion proteins | Q77208238 | ||
| Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins | Q77807280 | ||
| A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model | Q78844599 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 504-509 | |
| P577 | publication date | 2007-03-11 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes | |
| P478 | volume | 13 |
| Q37744810 | 'In vivo' optical approaches to angiogenesis imaging |
| Q43135196 | A molecular imaging paradigm to rapidly profile response to angiogenesis-directed therapy in small animals |
| Q40095056 | A new PET tracer specific for vascular endothelial growth factor receptor 2. |
| Q37172093 | A practical guide to the construction of radiometallated bioconjugates for positron emission tomography. |
| Q37214528 | A review of imaging agent development |
| Q35059899 | Advances in bio-optical imaging for the diagnosis of early oral cancer |
| Q37394193 | Alternative Non-Antibody Protein Scaffolds for Molecular Imaging of Cancer |
| Q37364420 | Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression. |
| Q26773577 | Angiogenic factors, bladder neuroplasticity and interstitial cystitis-new pathobiological insights |
| Q88349347 | Bevacizumab and near infrared probe conjugated iron oxide nanoparticles for vascular endothelial growth factor targeted MR and optical imaging |
| Q57708010 | Bispidines for Dual Imaging |
| Q50096541 | CCR7 Is Important for Mesangial Cell Physiology and Repair |
| Q35026967 | Cell-mediated Delivery and Targeted Erosion of Vascular Endothelial Growth Factor-Crosslinked Hydrogels |
| Q33525581 | Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma |
| Q24648786 | Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells |
| Q40026377 | Chapter 7. Molecular imaging of tumor vasculature |
| Q50511998 | Conjugated polymer and gold nanoparticle co-loaded PLGA nanocomposites with eccentric internal nanostructure for dual-modal targeted cellular imaging. |
| Q33870879 | Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease |
| Q24649911 | Delivery of optical contrast agents using Triton-X100, part 1: reversible permeabilization of live cells for intracellular labeling |
| Q37458674 | Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer |
| Q33637137 | Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation. |
| Q37487137 | Enhanced fluorescence diffuse optical tomography with indocyanine green-encapsulating liposomes targeted to receptors for vascular endothelial growth factor in tumor vasculature |
| Q33731672 | Fluorescence imaging of vascular endothelial growth factor in tumors for mice embedded in a turbid medium |
| Q52147085 | Gallium-68 Complexes Conjugated to Pittsburgh Compound B: Radiolabeling and Biological Evaluation. |
| Q38784255 | Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting |
| Q28484118 | Identification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2 |
| Q37833963 | Image-guided surgery in head and neck cancer: current practice and future directions of optical imaging. |
| Q52567951 | Imaging VEGF Receptors and αvβ3 Integrins in a Mouse Hindlimb Ischemia Model of Peripheral Arterial Disease. |
| Q36944432 | Imaging VEGF receptor expression to identify accelerated atherosclerosis |
| Q34977050 | Imaging and cancer: a review |
| Q35999557 | Imaging key biomarkers of tumor angiogenesis |
| Q37760628 | Imaging of the host/parasite interplay in cutaneous leishmaniasis |
| Q38341267 | In vivo Fluorescence Imaging of Tumors using Molecular Aptamers Generated by Cell‐SELEX |
| Q39253910 | In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models |
| Q27693338 | In vivo imaging of therapy-induced anti-cancer immune responses in humans |
| Q51363382 | In vivo monitoring of angiogenesis in a mouse hindlimb ischemia model using fluorescent peptide-based probes. |
| Q39966364 | In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment. |
| Q37837837 | In vivo small animal imaging: current status and future prospects |
| Q90611118 | In vivo ultrasound-switchable fluorescence imaging using a camera-based system |
| Q33736042 | In vivo, dual-modality OCT/LIF imaging using a novel VEGF receptor-targeted NIR fluorescent probe in the AOM-treated mouse model |
| Q37633122 | Inhibition of vascular endothelial growth factor receptor signaling in angiogenic tumor vasculature |
| Q37149571 | Intraoperative imaging in ovarian cancer: fact or fiction? |
| Q30465487 | Intravascular targets for molecular contrast-enhanced ultrasound imaging |
| Q38106488 | MarginProbe: intraoperative margin assessment during breast conserving surgery by using radiofrequency spectroscopy |
| Q34474669 | Modulation, bioinformatic screening, and assessment of small molecular peptides targeting the vascular endothelial growth factor receptor |
| Q43085872 | Molecular MRI of VEGFR-2 reveals intra-tumor and inter-tumor heterogeneity |
| Q53466644 | Molecular imaging can accelerate anti-angiogenic drug development and testing. |
| Q35130907 | Molecular imaging in tumor angiogenesis and relevant drug research |
| Q37825149 | Molecular imaging metrics to evaluate response to preclinical therapeutic regimens |
| Q36106634 | Molecular imaging of vascular endothelial growth factor receptors in graft arteriosclerosis |
| Q30481645 | Molecular imaging of vessels in mouse models of disease |
| Q30482989 | Molecular imaging: 18F-FDG PET and a whole lot more. |
| Q37827710 | Multimodal radio- (PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents. |
| Q41661199 | Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives |
| Q53443314 | Multiplexing with multispectral imaging: from mice to microscopy. |
| Q42584688 | Murine cytomegalovirus displays selective infection of cells within hours after systemic administration |
| Q35904723 | NIR fluorescent small molecules for intraoperative imaging |
| Q37289003 | Near infrared planar tumor imaging and quantification using nanosized Alexa 750-labeled phospholipid micelles |
| Q50533641 | Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: Assessing intraoperative techniques in tissue-simulating breast phantoms |
| Q39652806 | Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment. |
| Q36143288 | Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice |
| Q33655366 | Noninvasive assessment of tumor VEGF receptors in response to treatment with pazopanib: a molecular imaging study |
| Q37358262 | Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. |
| Q37855905 | Optical and magnetic resonance imaging as complementary modalities in drug discovery |
| Q37771289 | Optical image-guided surgery--where do we stand? |
| Q37946850 | Optical imaging for the new grammar of drug discovery |
| Q37769375 | Optical molecular imaging and its emerging role in colorectal cancer |
| Q37772807 | Optical techniques for the molecular imaging of angiogenesis |
| Q37058474 | Optical tecnology developments in biomedicine: history, current and future |
| Q37366243 | PET Imaging of Angiogenesis |
| Q36763112 | PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragment |
| Q41852844 | PIKfyve regulation of endosome-linked pathways |
| Q36637536 | Pilot Clinical Trial of Indocyanine Green Fluorescence-Augmented Colonoscopy in High Risk Patients |
| Q35646547 | Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab |
| Q34697688 | Positron emission tomography imaging of cancer biology: current status and future prospects |
| Q36586091 | Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment |
| Q36746567 | Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121. |
| Q36777285 | Positron emission tomography tracers for imaging angiogenesis |
| Q30475818 | Preclinical molecular imaging of tumor angiogenesis. |
| Q38716321 | Prolactin Receptor-Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity |
| Q54257268 | Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation. |
| Q36742911 | Protein-based tumor molecular imaging probes |
| Q39941113 | Quantitative PET imaging of VEGF receptor expression |
| Q33721349 | Quantum dot loaded immunomicelles for tumor imaging |
| Q51717661 | Quantum dot multiplexing for the profiling of cellular receptors. |
| Q38168932 | Radio-guided localization of clinically occult breast lesions: current modalities and future directions. |
| Q36420140 | Radiolabeling and evaluation of (64)Cu-DOTA-F56 peptide targeting vascular endothelial growth factor receptor 1 in the molecular imaging of gastric cancer |
| Q38789421 | Radiolabeling of VEGF165 with 99mTc to evaluate VEGFR expression in tumor angiogenesis. |
| Q38755295 | Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? |
| Q39661859 | SLT-VEGF reduces lung metastases, decreases tumor recurrence, and improves survival in an orthotopic melanoma model |
| Q38734446 | Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants. |
| Q51050077 | Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE-/- Mice. |
| Q53140407 | Single-chain VEGF/Cy5.5 targeting vegf receptors to indicate atherosclerotic plaque instability. |
| Q36072875 | Site-Specific Labeling of scVEGF with Fluorine-18 for Positron Emission Tomography Imaging |
| Q35999606 | Stroma targeting nuclear imaging and radiopharmaceuticals |
| Q39809361 | Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2. |
| Q39872482 | Synthesis and preclinical evaluation of [(11)C]PAQ as a PET imaging tracer for VEGFR-2. |
| Q35855490 | Targeted molecular imaging of angiogenesis in PET and SPECT: a review |
| Q36468606 | Targeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy |
| Q33696408 | Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs |
| Q37871875 | The challenges of integrating molecular imaging into the optimization of cancer therapy. |
| Q58093815 | The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation |
| Q38229334 | The effects of poststroke aerobic exercise on neuroplasticity: a systematic review of animal and clinical studies |
| Q39160179 | Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP. |
| Q30359568 | Ultrasound Molecular Imaging of Angiogenesis Using Vascular Endothelial Growth Factor-Conjugated Microbubbles. |
| Q30278971 | Ultrasound in Radiology: From Anatomic, Functional, Molecular Imaging to Drug Delivery and Image-Guided Therapy |
| Q37018478 | Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients |
| Q35162764 | Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer |
| Q34515175 | VEGF induces sensory and motor peripheral plasticity, alters bladder function, and promotes visceral sensitivity |
| Q36807118 | VEGF receptors and neuropilins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation. |
| Q30455612 | Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy |
| Q38957484 | Vascular targeting of nanoparticles for molecular imaging of diseased endothelium |
| Q34947014 | Whole cell-SELEX aptamers for highly specific fluorescence molecular imaging of carcinomas in vivo |
| Q38941700 | qFlow Cytometry-Based Receptoromic Screening: A High-Throughput Quantification Approach Informing Biomarker Selection and Nanosensor Development. |
| Q30425448 | scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis |
Search more.